| Old Articles: <Older 5161-5170 Newer> |
|---|
 |
ifeminists
October 5, 2008
Tony Zizza |
The over-prescribing of America In writing "Stigma often hinders lifesaving discussion" for The Tennessean on Sept. 17, Dr. Dennis Morrison offers us more recycled bromides concerning suicide and the state of mental health.   |
The Motley Fool
October 3, 2008
Brian Orelli |
Amgen Draws Blood in Anemia-Drug War The pharmaceutical fights off rival Roche. |
The Motley Fool
October 3, 2008
Brian Orelli |
Merck Can't Fight the Munchies The pharma gives up on its anti-obesity drug. |
The Motley Fool
October 2, 2008
Brian Orelli |
Will Johnson & Johnson Ever Get Its Money? For investors, there are a couple of lessons here. First, perhaps more than any other, the health care sector has a lot of lawsuits. |
The Motley Fool
October 2, 2008
Brian Orelli |
Will Lilly Buy ImClone's Troubles? Eli Lilly is reportedly ImClone's mystery suitor. Would it be a good deal? |
Chemistry World
October 1, 2008
Victoria Gill |
GSK to Cut 850 R&D Jobs GlaxoSmithKline has announced that up to 850 R&D jobs will be cut as it implements its new business strategy. |
The Motley Fool
October 1, 2008
Brian Orelli |
WuXi and Covance Call It Quits WuXi PharmaTech and Covance broke up yesterday - just three months after announcing they'd form an alliance to perform pre-clinical research for drug developers looking for research and development on the cheap. |
The Motley Fool
October 1, 2008
Brian Orelli |
Is Pfizer the Mystery Bidder? A few signals that Pfizer might be the one bidding on ImClone. |
The Motley Fool
October 1, 2008
Brian Orelli |
3 Drugmakers With Multiple Shots on Goal Well-stocked pipelines could kick these drugmakers into super-high gear. |
Chemistry World
October 2008
Derek Lowe |
Column: In the pipeline The author seeks a cure for 'compound bloat' |
| <Older 5161-5170 Newer> Return to current articles. |
